Organon (OGN) Change in Receivables (2020 - 2026)

Organon has reported Change in Receivables for 7 years, with the latest figure at $111.0 million in Q2 2026.

• On a quarterly basis, Change in Receivables rose 1333.33% year-over-year to $111.0 million in Q2 2026; TTM through Jun 2026 was $21.0 million, a 109.59% increase from a year earlier, with the FY2025 full-year figure at -$79.0 million, up 79.37% from the prior year.
• Change in Receivables was $111.0 million for Q2 2026 at Organon, up from $65.0 million in the prior quarter.
• The five-year high for Change in Receivables was $230.0 million in Q2 2023, with the low at -$341.0 million in Q4 2024.
• Average Change in Receivables over 5 years is $2.7 million, with a median of $4.5 million recorded in 2022.
• The sharpest annual moves came in 2024 and 2026: Change in Receivables slumped 1362.96% in 2024, then surged 1333.33% in 2026.
• Over 5 years, Change in Receivables stood at $4.0 million in 2022, then soared by 575.0% to $27.0 million in 2023, then plunged by 1362.96% to -$341.0 million in 2024, then soared by 53.08% to -$160.0 million in 2025, then jumped by 169.38% to $111.0 million in 2026.
• The last three Change in Receivables figures came in at $111.0 million (Q2 2026), $65.0 million (Q1 2026), and -$160.0 million (Q4 2025), per Business Quant data.